InsidersTradesSigma
Browse the full record of transactions filed by Santos David A, Director. Insider active across 1 company, notably RIGEL PHARMACEUTICALS INC. Cumulatively, 2 reports have been published. Activity tracked since 24 January 2022. The latest transaction was filed on 24 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
David A. Santos is the Executive Vice President and Chief Commercial Officer at Rigel Pharmaceuticals Inc. In this role, he oversees the company's commercial operations, contributing to the growth strategy. With experience in the pharmaceutical sector, he plays a key role in the leadership of Rigel Pharmaceuticals Inc.